We’ve looked at what it’s like to be a member of an MRC board, but what actually happens at a meeting? Katherine Nightingale sat in on part of a Panel session to find out.
In a large, bright room on the 13th floor of a London office block, 25 people are deciding how to spend up to £10 million. They are the MRC’s Developmental Pathway Funding Scheme (DPFS) Panel, charged with making decisions on applications for funding the development and testing of new therapies, medical devices and diagnostics.
The task at hand is to consider a set of 15 full applications seeking just over £15m for funding. Each application has already been the subject of considerable work from the Panel during the outline stage, which does what it says on the tin, with the Panel feeding back on a brief description of the project. Read more